Advertisement

Loading...

Markray Corp.

RVBRPNK
Consumer Defensive
Beverages - Non-Alcoholic
$0.06
$-0.02(-26.50%)
U.S. Market opens in 13h 6m

Markray Corp. Fundamental Analysis

Markray Corp. (RVBR) shows weak financial fundamentals with a PE ratio of -0.45, profit margin of 0.00%, and ROE of -1.92%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.06

Areas of Concern

ROE-1.92%
Operating Margin0.00%
Cash Position0.04%
Current Ratio0.00
We analyze RVBR's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -214.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-214.6/100

We analyze RVBR's fundamental strength across five key dimensions:

Efficiency Score

Weak

RVBR struggles to generate sufficient returns from assets.

ROA > 10%
-2.28%

Valuation Score

Excellent

RVBR trades at attractive valuation levels.

PE < 25
-0.45
PEG Ratio < 2
-0.06

Growth Score

Weak

RVBR faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

RVBR shows balanced financial health with some risks.

Debt/Equity < 1
0.00
Current Ratio > 1
0.00

Profitability Score

Weak

RVBR struggles to sustain strong margins.

ROE > 15%
-191.57%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is RVBR Expensive or Cheap?

P/E Ratio

RVBR trades at -0.45 times earnings. This suggests potential undervaluation.

-0.45

PEG Ratio

When adjusting for growth, RVBR's PEG of -0.06 indicates potential undervaluation.

-0.06

Price to Book

The market values Markray Corp. at 1.03 times its book value. This may indicate undervaluation.

1.03

EV/EBITDA

Enterprise value stands at -0.09 times EBITDA. This is generally considered low.

-0.09

How Well Does RVBR Make Money?

Net Profit Margin

For every $100 in sales, Markray Corp. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-1.92 in profit for every $100 of shareholder equity.

-1.92%

ROA

Markray Corp. generates $-2.28 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.28%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.07 in free cash annually.

$-0.07

FCF Yield

RVBR converts -7.86% of its market value into free cash.

-7.86%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.45

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.06

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.03

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.001

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.00

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.92

vs 25 benchmark

ROA

Return on assets percentage

-2.28

vs 25 benchmark

ROCE

Return on capital employed

-2.30

vs 25 benchmark

How RVBR Stacks Against Its Sector Peers

MetricRVBR ValueSector AveragePerformance
P/E Ratio-0.4522.46 Better (Cheaper)
ROE-191.57%1263.00% Weak
Net Margin0.00%-5207.00% (disorted) Weak
Debt/Equity0.001.24 Strong (Low Leverage)
Current Ratio0.002.47 Weak Liquidity
ROA-228.02%-192326.00% (disorted) Weak

RVBR outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Markray Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Dividend, Low Volatility

EPS CAGR

N/A

Industry Style: Defensive, Dividend, Low Volatility

FCF CAGR

N/A

Industry Style: Defensive, Dividend, Low Volatility

Fundamental Analysis FAQ